Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Asimilar Group Plc Director's Dealing 2020

Nov 24, 2020

6087_dirs_2020-11-24_d373a27a-e154-4f7f-8e27-ed1df8b1dc47.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2494G

Asimilar Group PLC

24 November 2020

Asimilar Group Plc

("Asimilar" or the "Company")

Director's Dealing

Asimilar Group Plc, the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), announces that, on 23 November 2020, Mark Horrocks, a Director of the Company, transferred 60,000 Asimilar ordinary shares representing 0.06 per cent. of the Company's issued ordinary share capital, from Intrinsic Capital Services Limited, which is wholly owned by Mark Horrocks, to a share account in his own name.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mark Horrocks

2

Reason for the notification

a)

Position/status

Non-executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Asimilar Group Plc

b)

LEI

213800AYJZ2B8QNY7H15

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.01 pence per share par value 

GB00BFX2VL54

b)

Nature of the transaction

Transfer of current shareholding

c)

Price(s) and volume(s)

Price(s) Volume(s)
22.5p 60,000

d)

Aggregated information

- Aggregated volume
- Price

As above

As above

e)

Date of the transaction

23 November 2020

f)

Place of the transaction

London Stock Exchange, AIM

Mr Horrocks' interest in Asimilar remains unchanged at 5,422,947 Asimilar ordinary shares, representing 5.04 per cent. of Asimilar's issued share capital.  In addition Mark Horrocks has warrants to subscribe for 1,000,000 Asimilar ordinary shares at an exercise price of 30 pence per Asimilar ordinary share and up to a further 9,000,000 Asimilar ordinary shares at an exercise price of 0.01 pence per Asimilar ordinary share in 2 tranches of up to 4,500,000 warrants per tranche.  Each tranche will be exercisable for two years after the relevant price criteria having been reached.  The relevant price criteria are the mid-market closing price of shares in Dev Clever Holdings plc for a period of five consecutive Business Days being or exceeding (i) 28 pence; and (ii) 55 pence respectively.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The Directors of the Company take responsibility for this announcement.

**ENDS**

Contacts

Asimilar Group plc
John Taylor, Non-Executive Chairman via Buchanan
Cairn Financial Advisers LLP
Sandy Jamieson / Liam Murray Tel: +44 20 7213 0880
Peterhouse Capital Limited
Duncan Vasey / Lucy Williams Tel: + 44 20 7220 9797
Buchanan Communications Limited
Richard Oldworth / Chris Lane Tel: +44 (0) 20 7466 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDXBDBRGDDGGX